Prior Authorization and Association With Delayed or Discontinued Prescription Fills.
Michael Anne KyleNancy L KeatingPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Introduction of a new prior authorization policy on an established drug regimen is associated with increased probability of discontinued and delayed care. For some conditions, this may represent a clinically consequential barrier to access. Waiving prior authorization for patients already established on a drug may improve adherence.
Keyphrases
- healthcare
- end stage renal disease
- newly diagnosed
- ejection fraction
- public health
- chronic kidney disease
- palliative care
- prognostic factors
- mental health
- quality improvement
- adverse drug
- drug induced
- metabolic syndrome
- pain management
- emergency department
- patient reported
- glycemic control
- chronic pain
- electronic health record